Wall Street Journal
Sam Bankman-Fried's FTX, Binance Reportedly In The Lead To Buy Voyager Digital's Assets
More Regulatory Watching For Amazon, $1.7B Proposed Purchase Of iRobot Attracts Attention
Reuters
Boeing To Axe 150 Finance Jobs In US Following Flight Debacles
CVS Health, Walmart Settle West Virginia Opioid Lawsuit, Walgreens To Face Trial Next Year
General Electric Hires Mavi Zingoni As Head Of Power Business
- General Electric Co (NYSE:GE) has appointed Mavi Zingoni as the Chief Executive Officer of its power units.
- Zingoni will report to Scott Strazik, who heads the company's portfolio of energy businesses.
- Zingoni will be based in the U.S. and will start work on January 1, 2023.
Financial Times
Pressure Mounts On US To Blacklist This Top Chinese Chipmaker
- Top U.S. lawmakers urged the Biden administration to blacklist Chinese semiconductor company Yangtze Memory Technologies Co for allegedly violating export controls by supplying Huawei Technologies Co, Ltd.
- As per the lawmakers, YMTC has provided Nand memory chips for Huawei's new flagship foldable phone, Mate Xs 2.
- In 2019, the U.S. blacklisted Huawei citing national security risks.
Schneider Electric To Buyout UK Software Developer Aveva At 40% Premium
Benzinga
Twitter, Microsoft To Invest Toward Christchurch Call Anti-Online Hate Project, Says New Zealand PM
Juul Sues FDA, Accuses It Deliberately Withheld Scientific Materials Related To Sales Ban
FDA Concludes Oversight Shortcomings After Infant Formula Internal Review
Beyond Meat Suspends COO Following Arrest Over Nose Biting Incident
Volkswagen's Chinese EV Battery Maker Plans $3.6B Michigan Plant That Could Create Up To 2,000 Jobs
Tesla Megapack Battery Fire In California That Shut Major Highway Is Now 'Fully Controlled'
YouTube Does A TikTok: Shorts Creators Will Now Get Share Of Ad Revenue
Germany Moves To Nationalize Gas Giant Uniper In €8B Deal To Avert Energy Supply Crisis
Novartis To Petition US Supreme Court To Uphold Patent Validity For Multiple Sclerosis Drug, Gilenya
- Swiss drug major Novartis AG (NYSE:NVS) plans to petition the U.S. Supreme Court to uphold the validity of the Gilenya (fingolimod) dosing regimen patent.
- With the latest decision, HEC and other generic application filers with FDA approval will potentially be able to launch a generic version of 0.5mg Gilenya imminently.
French Billionaire Xavier Niel Scoops 2.5% Stake In Vodafone
Photo via Wikimedia Commons
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
